Literature DB >> 9467651

Revisiting the Th1/Th2 paradigm.

E Muraille1, O Leo.   

Abstract

The identification of subsets of CD4+ helper cells producing distinct pattern of cytokines has provided a valuable framework for understanding how different effector populations of immune cells can be recruited in vivo during infection. In the view of most investigators, Th1 and Th2 cells produce factors that serve as their own autocrine factors and cytokines exerting suppressive activities on each other's development and activity. This concept intuitively explains the natural tendency of immune responses to become progressively polarized. However, several experimental observations appear difficult to rationalize with a simple, 'symmetrical' Th1/Th2 paradigm including those that Th1 cells do not produce their own growth factor; that both Th1 and Th2 cells can promote inflammatory responses; that interleukin-10 (IL-10) inhibits inflammatory responses in a Th1/Th2-independent fashion; that IL-10 promotes the development of Th1-type effector cells; and that IL-12 can amplify pre-established Th2 responses. The purpose of the present analysis is to provide a revised model for better understanding how cytokines regulate immune responses in vivo.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9467651     DOI: 10.1111/j.1365-3083.1998-47-1.00383.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  24 in total

1.  Activation of mononuclear cells by interleukin-12: an in vivo study in chimpanzees.

Authors:  F N Lauw; A A te Velde; P E Dekkers; P Speelman; J M Aerts; C E Hack; S J van Deventer; T van der Poll
Journal:  J Clin Immunol       Date:  1999-07       Impact factor: 8.317

2.  The effect of interleukin-10 and of interleukin-12 on the in vitro production of anti-double-stranded DNA antibodies from patients with systemic lupus erythematosus.

Authors:  J Tyrrell-Price; P M Lydyard; D A Isenberg
Journal:  Clin Exp Immunol       Date:  2001-04       Impact factor: 4.330

Review 3.  Anti-inflammatory defense mechanisms of Entamoeba histolytica.

Authors:  Raúl Silva-García; Guadalupe Rico-Rosillo
Journal:  Inflamm Res       Date:  2010-10-12       Impact factor: 4.575

Review 4.  Human and Pathogen Factors Associated with Chlamydia trachomatis-Related Infertility in Women.

Authors:  S Menon; P Timms; J A Allan; K Alexander; L Rombauts; P Horner; M Keltz; J Hocking; W M Huston
Journal:  Clin Microbiol Rev       Date:  2015-10       Impact factor: 26.132

Review 5.  Current status and challenges of cytokine pharmacology.

Authors:  Z Zídek; P Anzenbacher; E Kmonícková
Journal:  Br J Pharmacol       Date:  2009-04-03       Impact factor: 8.739

6.  Antiviral treatment of hepatitis B virus-transgenic mice by a marine organism, Styela plicata.

Authors:  Rui Wang; Zhen-Lan Du; Wen-Jun Duan; Xin Zhang; Fan-Lin Zeng; Xin-Xiang Wan
Journal:  World J Gastroenterol       Date:  2006-07-07       Impact factor: 5.742

7.  Comorbidity and lifestyle, reproductive factors, and environmental exposures associated with rheumatoid arthritis.

Authors:  A Reckner Olsson; T Skogh; G Wingren
Journal:  Ann Rheum Dis       Date:  2001-10       Impact factor: 19.103

8.  Both Th1 and Th2 cytokines affect the ability of monoclonal antibodies to protect mice against Cryptococcus neoformans.

Authors:  D O Beenhouwer; S Shapiro; M Feldmesser; A Casadevall; M D Scharff
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

Review 9.  Fatty acids, the immune response, and autoimmunity: a question of n-6 essentiality and the balance between n-6 and n-3.

Authors:  Laurence S Harbige
Journal:  Lipids       Date:  2003-04       Impact factor: 1.880

10.  First evidence of a pro-inflammatory response to severe infection with influenza virus H1N1.

Authors:  Isabel Fernández de Castro; María Guzmán-Fulgencio; Mónica García-Alvarez; Salvador Resino
Journal:  Crit Care       Date:  2010-02-11       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.